Journal of Urban Health

, Volume 82, Issue 3, pp 434–445

HIV among injection drug users in large US metropolitan areas, 1998

Authors

    • Institute for AIDS ResearchNational Development and Research Institutes
    • Department of Epidemiology, Bloomberg School of Public HealthJohns Hopkins University
  • Spencer Lieb
    • Bureau of HIV/AIDSFlorida Department of Health
  • Barbara Tempalski
    • National Development and Research Institutes, Inc.
  • Hannah Cooper
    • Medical and Health Research Association of New York/National Development and Research Institutes, Inc.
    • Columbia Mailman School of Public Health
  • Marie Keem
    • National Development and Research Institutes, Inc.
  • Risa Friedman
    • National Development and Research Institutes, Inc.
  • Peter L. Flom
    • Statistics and Data Analysis CoreNational Development and Research Institutes, Inc.
Article

DOI: 10.1093/jurban/jti088

Cite this article as:
Friedman, S.R., Lieb, S., Tempalski, B. et al. J Urban Health (2005) 82: 434. doi:10.1093/jurban/jti088

Abstract

This article estimates HIV prevalence rates among injection drug users (IDUs) in 95 large US metropolitan areas to facilitate social and policy analyses of HIV epidemics. HIV prevalence rates among IDUs in these metropolitan areas were calculated by taking the mean of two estimates: (1) estimates based on regression adjustments to Centers for Disease Control and Prevention (CDC) Voluntary HIV Counseling and Testing data and (2) estimates based on the ratio of the number of injectors living with HIV to the number of injectors living in the metropolitan area. The validity of the resulting estimates was assessed. HIV prevalence rates varied from 2 to 28% (median 5.9%; interquartile range 4.0–10.2%). These HIV prevalence rates correlated with similar estimates calculated for 1992 and with two theoretically related phenomena: laws against over-the-counter purchase of syringes and income inequality. Despite limitations in the accuracy of these estimates, they can be used for structural analyses of the correlates, predictors and consequences of HIV prevalence rates among drug injectors in metropolitan areas and for assessing and targeting the service needs for drug injectors.

Keywords

Epidemic modelingHIV prevalence estimatesInjection drug usersLocal epidemicsStructural analysis
Download to read the full article text

Copyright information

© Oxford University Press on behalf of the New York Academy of Medicine 2005